ziprasidone has been researched along with raclopride in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audinot, V; Chaput, C; Conte, C; Gavaudan, S; Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bench, CJ; Cuddigan, M; Dolan, RJ; Frackowiak, RS; Grasby, PM; Gunn, K; Lammertsma, AA; Osman, S; Turton, DJ; Warrington, SJ | 1 |
| Bench, CJ; Brooks, DJ; Frackowiak, RS; Gunn, K; Hume, SP; Lammertsma, AA; Osman, S | 1 |
| Bench, CJ; Boyce, M; Brannick, LY; Dolan, RJ; Frackowiak, RS; Grasby, PM; Gunn, KP; Lammertsma, AA; Warrington, SJ | 1 |
| Kapur, S; Mamo, D; Mann, S; Papatheodorou, G; Remington, G; Shammi, CM; Therrien, F | 1 |
| Bartenstein, P; Boy, C; Bröcheler, A; Buchholz, HG; Cumming, P; Fellows, C; Gründer, G; Hiemke, C; Janouschek, H; Landvogt, C; Rösch, F; Schäfer, W; Spreckelmeyer, K; Vernaleken, I; Veselinovic, T; Wong, DF | 1 |
| Borlido, C; Caravaggio, F; Deluca, V; Graff-Guerrero, A; Ismail, Z; Mamo, D; Mulsant, B; Pollock, B; Remington, G; Suzuki, T; Uchida, H | 1 |
5 trial(s) available for ziprasidone and raclopride
| Article | Year |
|---|---|
Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride.
Topics: Adult; Brain; Cerebrovascular Circulation; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Image Processing, Computer-Assisted; Male; Neostriatum; Piperazines; Prolactin; Raclopride; Receptors, Dopamine D2; Salicylamides; Spiro Compounds; Thiazoles; Tomography, Emission-Computed | 1993 |
The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography.
Topics: Adult; Antipsychotic Agents; Corpus Striatum; Humans; Male; Piperazines; Prolactin; Raclopride; Receptors, Dopamine D2; Salicylamides; Thiazoles; Time Factors; Tomography, Emission-Computed | 1996 |
A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
Topics: Adult; Antipsychotic Agents; Brain; Corpus Striatum; Drug Administration Schedule; Female; Humans; Male; Piperazines; Psychotic Disorders; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Schizophrenia; Thiazoles; Tomography, Emission-Computed | 2004 |
Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benzamides; Binding, Competitive; Carbon Radioisotopes; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Fluorine Radioisotopes; Humans; Male; Piperazines; Positron-Emission Tomography; Pyrrolidines; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Thiazoles; Time Factors; Young Adult | 2008 |
Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study.
Topics: Adult; Antipsychotic Agents; Brain; Case-Control Studies; Dopamine Antagonists; Female; Half-Life; Humans; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Prolactin; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Thiazoles; Time Factors; Young Adult | 2013 |
3 other study(ies) available for ziprasidone and raclopride
| Article | Year |
|---|---|
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Topics: Animals; Antipsychotic Agents; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sulfur Radioisotopes | 1998 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of methods for analysis of clinical [11C]raclopride studies.
Topics: Adult; Antipsychotic Agents; Body Fluid Compartments; Brain; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Male; Models, Biological; Nonlinear Dynamics; Piperazines; Raclopride; Receptors, Dopamine D2; Reference Values; Regression Analysis; Salicylamides; Thiazoles; Tissue Distribution; Tomography, Emission-Computed | 1996 |